CBC
cannabichromene
pronounced: kan-uh-bih-KROH-meen
A quiet, non-intoxicating cannabinoid studied for pain and mood.
Cannabichromene · 314.5 g/mol
The molecule
Chemical structure
This is the accurate skeletal structure of CBC, drawn from PubChem data. Each corner and line-end is a carbon atom, and the red O marks oxygen. Its formula is C21H30O2 and it weighs 314.5 g/mol.
About
What is CBC?
Cannabichromene, or CBC, is one of the four most common cannabinoids in cannabis, alongside THC, CBD and CBG, yet most people have never heard of it. It does not make you high.
Like the others, CBC starts as an acid, CBCA, made from the mother cannabinoid CBGA, and it appears once the plant is heated.
In the body
How CBC Works
CBC barely touches the CB1 receptor, which is why it is not intoxicating. It does switch on the CB2 receptor, and it strongly activates the body's TRP channels, which sense pain and heat. This may be how it helps with discomfort.
Laboratory research has looked at CBC for pain, mood and inflammation, and even at how it might support brain cells. Like many minor cannabinoids, it is thought to work best as part of a team, the "entourage effect", rather than alone.
Receptor snapshot
Where CBC Acts
The endocannabinoid system has two main receptors. Here is how strongly CBC acts on each.
Barely touches CB1, so it is not intoxicating.
Does activate CB2, which is linked to inflammation.
In the plant
How CBC is Made
CBC is made from CBCA, which the plant produces from CBGA using an enzyme called CBCA synthase.
Heating turns CBCA into CBC. Over time, and with strong light, CBC can slowly change again into another cannabinoid called CBL.
Good to know
Safety and Side Effects
CBC appears to be well tolerated, with little sign of serious side effects in the limited research so far. Because human studies are scarce, its long-term safety is not fully known.
As always, tell your prescriber before adding a new cannabinoid to your routine.
Questions
CBC: Common Questions
Is CBC intoxicating?
What does CBC do?
References
- DeLong, G.T., Wolf, C.E., Poklis, A. and Lichtman, A.H. (2010) 'Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by delta-9-tetrahydrocannabinol', Drug and Alcohol Dependence, 112(1-2), pp. 126-133. doi: 10.1016/j.drugalcdep.2010.05.019.
- Izzo, A.A., Borrelli, F., Capasso, R., Di Marzo, V. and Mechoulam, R. (2009) 'Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb', Trends in Pharmacological Sciences, 30(10), pp. 515-527. doi: 10.1016/j.tips.2009.07.006.
- Morales, P., Hurst, D.P. and Reggio, P.H. (2017) 'Molecular targets of the phytocannabinoids: a complex picture', Progress in the Chemistry of Organic Natural Products, 103, pp. 103-131. doi: 10.1007/978-3-319-45541-9_4.
- National Center for Biotechnology Information (2025) PubChem Compound Database. Bethesda: U.S. National Library of Medicine. Available at: https://pubchem.ncbi.nlm.nih.gov (Accessed: 29 July 2026).